Position in ICCC
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$984
+$983 QoQ
Shares Held
98
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 30 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ICCC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Capital Advisors, Ltd. LLC holds $457,986 across 47 Biotechnology names. ICCC ranks #27 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CDXS |
Codexis, Inc.
|
28,890 | $65,291 | |
| 2 | PCVX |
Vaxcyte, Inc.
|
1,000 | $58,130 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
99 | $49,176 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
162 | $48,766 | |
| 5 | EXEL |
Exelixis, Inc.
|
731 | $39,773 | |
| 6 | VNDA |
Vanda Pharmaceuticals Inc.
|
5,000 | $30,600 | |
| 7 | CGEM |
Cullinan Therapeutics, Inc.
|
1,600 | $29,136 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
295 | $23,390 |
All Filings in ICCC
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $984 | 98 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $1 | 98 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $1 | 98 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $1 | 98 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $1 | 98 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $469 | 98 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $1 | 100 | Shares | Sole | 2025-02-04 | |
| No filing history on record for this holder in this stock. | ||||||